Heart Test Laboratories, Inc., a company listed in the United States under the stock code HSCS.US, has been informed by the Securities and Exchange Commission (SEC) that its Registration Statement on Form S-1, filed on March 5, 2024, will not undergo review by the commission. The SEC's communication, dated March 11, 2024, was addressed to Andrew Simpson, the Chief Executive Officer of Heart Test Laboratories. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. For further inquiries, the SEC has provided contact information for Benjamin Richie.

Heart Test Laboratories, Inc., a company listed in the United States under the stock code HSCS.US, has been informed by the Securities and Exchange Commission (SEC) that its Registration Statement on Form S-1, filed on March 5, 2024, will not undergo review by the commission. The SEC's communication, dated March 11, 2024, was addressed to Andrew Simpson, the Chief Executive Officer of Heart Test Laboratories. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. For further inquiries, the SEC has provided contact information for Benjamin Richie.